期刊文献+

西妥昔单抗联合化疗治疗32例晚期肿瘤患者的毒副反应观察与护理 被引量:2

Monitoring and nursing care of toxicity reactions in 32 patients treated with cetuximab combined chemotherapy
原文传递
导出
摘要 32例应用西妥昔单抗联合化疗治疗,晚期恶性肿瘤的毒副反应观察与护理。护理重点:用药前给予针对性的心理护理;使用时严格遵循用药方法;用药后密切观察毒副反应,及时作出处理和相应的护理干预。本组治疗过程中2例出现过敏反应,3例出现Ⅲ°皮疹,经对症处理后好转,所有患者均按时完成了药物治疗。 This paper introduce the observation and nursing care of toxicity reactions in thirty-two advanced cancer patients treated with cetuximab combined chemotherapy. The nursing measures focused on pre-treatment psychological nursing,strictly abiding by the cetuximab combined chemotherapy protocols,as well as close monitoring and nursing interventions of toxicity reactions. All the thirty-two patients accomplished the cetuximab combined chemotherapy. During the drug therapy,two patients suffered from allergic reaction and three patients with grade Ⅲ skin rash. All the toxicity reactions were alleviated after treatment.
出处 《中华护理杂志》 CSCD 北大核心 2009年第8期700-702,共3页 Chinese Journal of Nursing
关键词 药物疗法 联合 肿瘤 护理 Drug Therapy,Combination Neoplasms Nursing Care
作者简介 雍定丽:女,本科,护师,E-mail:daisy911@live.cn
  • 相关文献

参考文献2

二级参考文献17

  • 1崔岚,逄晓云,王晓珉.新型抗肿瘤药物西妥昔单抗[J].中国药师,2005,8(4):332-334. 被引量:16
  • 2Fukuoka M,et al.Multi-institutional randomized phase Ⅱ trial of Gefitinib for previously treated patients with advanced non-small-cell lung cancer[J].J Clin Oncol,2003,21(12):2237-2246.
  • 3Baselga J.Why the epidermal growth factor receptor? The rationale for cancer therapy[J].Oncologist,2002,7Supp14:2-8.
  • 4Huang SM,et al.Epidermal growth factor receptor blockade with C225 modulates proliferation,apoptosis,and radiosensitivity in squamous cell carcinomas of the head and neck[J].Cancer Res,1999,59(8):1935-1940.
  • 5Karashima T,et al.Inhibition of Angiogenesis by the Antiepidermal Growth Factor Receptor Antibody ImClone C225 in Androgen-independent Prostate Cancer Growing Orthotopically in Nude Mice[J].Clin Cancer Res,2002,8:1253-1264.
  • 6Milas L,et al.In vivo enhancement of tumor radioresponse by C225antiepidermal growth factor receptor antibody[J].Clin Cancer Res,2000,6:701-708.
  • 7Robert F,et al.Phase I studies of anti-epidermal growth factor receptor antibody cetuximabin combination with radiation therapy in patients with advanced head and neck cancer[J].J Clin Oncol,2001,19(13):3234-3243.
  • 8Baselga J,et al.Phase 1 studies of anti-epidermal growth factor receptor chimeric antibody C225 alone and in combination with cisplatin[J].J Clin Oncol,2000,18:904-914.
  • 9aleh MN,et al.Combined modality therapy of A431 human epidermoid cancer using anti-EGFR antibody C225and radiation[J].Cancer Biother Radio-pharm,1999,14∶451.
  • 10Saltz L,et al.The presence and intensity of the cetuximab-induced acne-like rash predicts increased survival in studies across multiple malignancies[J].Proc Am Soc Clin Oncol,2003,22:204a.

共引文献68

同被引文献5

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部